口服米诺西迪尔用于脱发治疗:风险,益处和建议
Michael M Ong1, Yingjoy Li2, Shari R Lipner3
1Weill Cornell Medicine, New York, NY, USA.
American journal of clinical dermatology
|October 21, 2025
概括
低剂量口服米诺克西迪尔是一种有效的治疗各种脱发条件,提供与局部应用相似的结果. 它在坚持性和成本方面具有优势,在适当使用时具有可管理的副作用.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低剂量口服米诺克西迪尔越来越多地用于脱发.
- 最初是一种抗高血压药,其头发生长机制涉及KATP通道,Wnt/β-catenin信号传递和其他途径.
研究的目的:
- 审查低剂量口服米诺西迪尔治疗脱发的疗效和安全性.
- 概述当前关于标准化剂量和禁忌的共识.
主要方法:
- 临床研究和国际Delphi共识的审查.
- 对疗效,副作用和推剂量的分析.
主要成果:
- 口服米诺克西迪尔的疗效与局部米诺克西迪尔的疗效相当,粘附性更好.
- 常见的副作用包括高三和流血;严重的并发症很少见.
- 对于男性和女性,存在标准化剂量建议,针对青少年和特定健康状况进行调整.
结论:
- 低剂量口服米诺克西迪尔是治疗脱发障碍的安全有效选择.
- 对于长期结果和儿科使用,需要进一步的研究.
更多相关视频
03:22Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
15.5K
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
2.2K
相关概念视频
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
536
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
536
